Albion Financial Group Moderna, Inc. Transaction History

Albion Financial Group

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$126.46 - $235.05 $130,886 - $243,276	-1,035 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$225.82 - $368.51 $6,774 - $11,055	-30 Reduced 2.82%	1,035 $263,000
Q3 2021 Oct 19, 2021	SELL	$221.9 - $484.47 $5,547 - $12,111	-25 Reduced 2.29%	1,065 $410,000
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $138,354 - $250,253	1,065 Added 4260.0%	1,090 $256,000
Q4 2020 Feb 19, 2021	BUY	$65.74 - $169.86 $1,643 - $4,246	25 New	25 $3,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

Stay updated on Albion Financial Group with notifications on news.